HomeNewsBusinessStocksBuy Maruti Suzuki, DLF, Ajanta Pharma: Ashwani Gujral
Trending Topics
Sensex Live
Sudeep Pharma IPO
Gallard Steel IPO
Excelsoft Tech IPO
Gold Price

Buy Maruti Suzuki, DLF, Ajanta Pharma: Ashwani Gujral

Ashwani Gujral of ashwanigujral.com is of the view that one may buy Maruti Suzuki, DLF and Ajanta Pharma.

CNBC-TV18
November 17, 2017 / 15:25 IST
Story continues below Advertisement
Remove Ad

Your browser doesn't support HTML5 video.

Ashwani Gujral of ashwanigujral.com told CNBC-TV18, "One may buy DLF with a stoploss of Rs 218 and target of Rs 234."

"One may buy Ajanta Pharma with a stoploss of Rs 1240 and target of Rs 1320."

Story continues below Advertisement
Remove Ad

"One may buy Maruti Suzuki with a stoploss of Rs 8260 and target of Rs 8420."

CNBC-TV18
first published: Nov 17, 2017 02:33 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Follow Us On: Facebook twitter instagram linkedin telegram youtube
News
Business New Market New Stocks Income Tax Calculator Election Schedule 2024 India News Economy Mutual Funds Personal Finance IPO News Startups New USA Elections New
Features
Gold Rate Today Silver Rate Today Trending News Startups New National News MC Videos MC You Tube
Tools
SIP Calculator 2 SIP Calculator 3 SIP Calculator 1 New SIP Calculator 4
Specials
PowerYourTrade Master Your Money Game Changers
Network 18 Sites
News18 Firstpost CNN News18 CNBC TV18 Forbes History TV18
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker Fixed Deposits Fixed Deposit Comparison Fixed Income Account Aggregator
Quick Links
About Us New Contact Us Advisory Alert New Advertise with Us New Disclaimer Privacy Policy Cookie Policy Terms & Conditions Careers Financial Terms (Glossary) Analytical & Information Tool New
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.